SecSonar.com

Molecular Partners AG (MOLN)

Molecular Partners AG at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Molecular Partners AG (MOLN) is a Biotechnology company based in CH with a market capitalization of $148.2M. Free cash flow was negative at -$64.7M. This page tracks MOLN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

CH · 158 employees · IPO Jun 16, 2021

Valuation

Valuation & price

$3.84 · as of May 17, 2026 · -25.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.84

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$5.13$4.30$3.47Jul 25Dec 25Jul 26Jul 7, 25$3.61Jul 9, 25$3.58Jul 11, 25$3.59Jul 15, 25$3.57Jul 17, 25$3.65Jul 21, 25$3.85Jul 23, 25$3.90Jul 25, 25$3.87Jul 29, 25$3.95Jul 31, 25$3.70Aug 4, 25$3.65Aug 6, 25$3.48Aug 11, 25$3.47Aug 13, 25$3.56Aug 15, 25$3.47Aug 19, 25$3.47Aug 21, 25$3.55Aug 25, 25$4.22Aug 27, 25$3.75Aug 29, 25$3.75Sep 3, 25$3.72Sep 5, 25$3.58Sep 9, 25$3.72Sep 11, 25$3.75Sep 16, 25$3.64Sep 18, 25$3.69Sep 22, 25$3.67Sep 24, 25$3.68Sep 26, 25$3.85Sep 30, 25$3.71Oct 2, 25$3.71Oct 6, 25$3.75Oct 8, 25$3.89Oct 10, 25$3.80Oct 14, 25$3.73Oct 16, 25$3.85Oct 21, 25$3.70Oct 23, 25$3.56Oct 27, 25$3.59Oct 29, 25$3.75Oct 31, 25$3.63Nov 4, 25$3.91Nov 6, 25$4.68Nov 10, 25$4.25Nov 12, 25$4.13Nov 14, 25$4.22Nov 18, 25$4.12Nov 20, 25$4.12Nov 25, 25$4.00Nov 28, 25$4.12Dec 2, 25$4.32Dec 4, 25$4.51Dec 8, 25$4.20Dec 10, 25$4.28Dec 12, 25$4.33Dec 16, 25$4.18Dec 18, 25$4.28Dec 22, 25$4.59Dec 24, 25$4.34Dec 29, 25$4.43Jan 2, 26$4.22Jan 6, 26$4.38Jan 8, 26$4.25Jan 12, 26$4.17Jan 14, 26$4.21Jan 16, 26$4.20Jan 21, 26$4.04Jan 23, 26$4.09Jan 27, 26$4.00Jan 29, 26$4.15Feb 2, 26$4.57Feb 4, 26$4.40Feb 9, 26$4.65Feb 11, 26$4.65Feb 13, 26$4.61Feb 18, 26$4.73Feb 20, 26$5.00Feb 24, 26$5.02Feb 26, 26$4.88Mar 2, 26$5.13Mar 4, 26$4.93Mar 6, 26$5.00Mar 10, 26$4.88Mar 12, 26$4.71Mar 17, 26$4.34Mar 19, 26$4.69Mar 23, 26$4.51Mar 25, 26$4.31Mar 27, 26$4.05Mar 31, 26$3.97Apr 2, 26$3.85Apr 7, 26$3.87Apr 9, 26$4.33Apr 13, 26$4.21Apr 15, 26$4.20Apr 17, 26$4.21Apr 22, 26$4.34Apr 24, 26$4.46Apr 28, 26$4.28Apr 30, 26$4.23May 4, 26$4.41May 6, 26$4.29May 8, 26$4.10May 12, 26$4.04May 14, 26$3.84May 18, 26$3.80May 20, 26$3.74May 22, 26$4.18May 28, 26$4.00Jun 1, 26$3.95Jun 3, 26$4.03Jun 5, 26$4.10Jun 9, 26$3.88Jun 11, 26$3.71Jun 15, 26$3.85Jun 17, 26$3.90Jun 22, 26$3.95Jun 24, 26$3.80Jun 26, 26$3.80Jul 2, 26$3.98
$3.4752-week range$5.13
Loading valuation history…

Fundamentals

Key fundamentals

$148.2M

Market cap

—

Revenue growth (YoY)

-855.8%

Gross margin

-$64.7M

Free cash flow (USD)

-$89.4M

Net debt

Net cash position

9.5%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$23.0MFY 2017$20.0MFY 2018$10.4MFY 2019$20.4MFY 2020$9.3MFY 2021$9.3MFY 2022$189.6MFY 2023$7.0MFY 2024$5.0MFY 2025$0.00
$23M$0

Free cash flow by year

2016 → 2025

FY 2016$-36.5MFY 2017$-40.5MFY 2018$-43.3MFY 2019$-3.1MFY 2020$-30.7MFY 2021$-92.3MFY 2022$117.1MFY 2023$-59.6MFY 2024$-60.0MFY 2025$-52.0M
-$36.5M-$52M

Gross margin by year

2021 → 2024

FY 2021-497.2%FY 202273.2%FY 2023-579.8%FY 2024-855.8%
-497.2%-855.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingFirst Patients DosedJul 2, 2026Filing
  • 6-K filingPresentations at ASCO and SNMMIJun 1, 2026Filing
  • Annual reportAnnual Report FiledMay 12, 2026Filing
  • 6-K filingPhase 1 Data AnnouncementMay 1, 2026Filing
  • 6-K filingBoard Proposals ApprovedApr 14, 2026Filing

Questions

Frequently asked questions

What is Molecular Partners AG's market cap?

Molecular Partners AG (MOLN) has a market capitalization of $148.2M.

What is MOLN's P/E ratio?

A meaningful P/E ratio is not available for MOLN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is MOLN's price-to-book (P/B) ratio?

MOLN trades at 1.84 times book value per share.

Are insiders buying MOLN stock?

SEC Form 4 filings show no open-market insider buys at Molecular Partners AG in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

CNTB

Connect Biopharma Holdings Limited

$151.1M

IVVD

Invivyd, Inc.

$151.3M

ADAG

Adagene Inc.

$152.5M

AGEN

Agenus Inc.

$139.1M

MDWD

MediWound Ltd.

$157.8M

UNCY

Unicycive Therapeutics, Inc.

$158.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.